ML
CLVS

McAdam LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

McAdam LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,842
Closed -$63K – 173
2020
Q3 		$63K Sell
10,842
-6,690
-38% -$40K 0.01% 139
2020
Q2 		$118K Sell
17,532
-9,883
-36% -$74.8K 0.03% 121
2020
Q1 		$174K Buy
27,415
+12,180
+80% +$97.7K 0.05% 100
2019
Q4 		$159K Buy
15,235
+3,045
+25% +$22.1K 0.04% 85
2019
Q3 		$48K Buy
+12,190
New +$98.6K 0.01% 82

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return